Dr. Julhash U. Kazi is an Associate Professor of Molecular Medicine at Lund University, Sweden, where he investigates the molecular mechanisms of therapy resistance in cancer. He completed his Ph.D. in Biomedical Research at Inha University in South Korea in 2009, then joined Lund University’s Medical Faculty. His research extends to the early detection of malignant diseases, a critical challenge in oncology. In addition to academic responsibilities, he serves as a section editor for Hereditas, a journal focusing on genetics and genomics, and as an AI consultant for start-ups. Dr. Kazi has published over 90 articles, including 11 book chapters, covering a broad spectrum of topics in cancer biology, personalized medicine, and applied AI.